Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019979 220009649 null 76.1 null 2015-06-19 2015-09-30 MITOXANTRONE + TRETINOIN N N 220036654 INTERFERON
220019981 220009656 1.68 82 Curative (C) 2018-02-15 2018-02-15 Cetuximab 7 day (>Cycle 2) 02 N 220036675 MERCAPTOPURINE
220019982 220009659 1.76 76 Palliative (P) 2018-06-21 2018-06-22 Cisplatin +Fluorouracil (3 wk) null null 220036683 BORTEZOMIB
220019983 220009668 1.53 60 Curative (C) 2015-08-29 2015-09-05 CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA N N 220036733 FIGARO TRIAL
220019984 220009669 1.49 67 Curative (C) 2014-01-24 2014-01-24 ALL UKALL2003 TRIAL N N 220036735 ARSENIC TRIOXIDE + ATRA
220019985 220009674 1.7 80.3 null 2018-09-15 2018-10-14 QUASAR 2 TRIAL N N 220036750 ATG + BUSULFAN + FLUDARABINE + THIOTEPA
220019986 220009677 1.53 83 Neo-adjuvant (N) 2018-08-12 2018-11-04 EOX N N 220036760 TRASTUZUMAB EMTANSINE
220019987 220009680 null null Palliative (P) 2013-08-15 2013-08-15 NHL 2003 Gp B COP N N 220000653 MITOXANTRONE + TRETINOIN
220019988 220009683 1.65 79 Palliative (P) 2016-03-01 2016-04-17 Cisplatin + Docetaxel +Fluorouracil N N 220002814 EOX
220019989 220009688 1.74 72.5 Curative (C) 2015-10-14 2016-10-23 ATG + Busulfan + Fludarabine + Thiotepa 2 N 220003896 PEMBROLIZUMAB
220019990 220015113 1.58 91.5 Palliative (P) 2017-01-05 2017-04-25 Alemtuzumab + Cyclophos TBI Allo N Y 220004682 ATG + BUSULFAN + FLUDARABINE + THIOTEPA
220019991 220009700 1.36 null Palliative (P) 2018-10-14 2018-11-02 PEMBROLIZUMAB null N 220014128 SPANISH MAINTENANCE
220019992 220018243 null 114 Palliative (P) 2018-05-22 2018-05-27 Alemtuz+Cyclophos+Fludara Allo 2 N 220016525 BUSULPHAN
220019993 220009710 null null Palliative (P) 2013-12-14 2014-03-31 IGEV R null null 220017673 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220019994 220015126 null null null 2018-04-05 2018-04-21 CYTARABINE + FLUDARABINE + IDARUBICIN null N 220018242 DHAP
220019995 220009725 1.24 null Palliative (P) 2014-02-01 2014-02-01 CVAD N N 220020796 CISPLATIN + FLUOROURACIL
220019996 220009730 1.67 70 Palliative (P) 2015-02-20 2015-03-30 DABRAFENIB + TRAMETINIB 02 N 220021070 DABRAFENIB + TRAMETINIB
220019997 220009734 1.83 76.6 null 2014-11-23 2015-05-11 Cytarabine+Methotrexate Intrathecal null null 220021758 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220019998 220015133 1.57 71.1 Curative (C) 2017-12-28 2018-01-05 Mercaptopurine N N 220021916 CHOP R
220019999 220015133 1.67 73 Disease modification (D) 2018-09-17 2019-07-14 Arsenic Triox + Tretinoin Ind W1-4 02 N 220021916 CAMELLIA TRIAL
220020000 220009741 1.73 17.1 null 2015-01-05 2015-04-25 AML Relapsed FLA 02 N 220022309 CARBOPLATIN + IRINOTECAN
220020001 220021034 null null Palliative (P) 2015-02-23 2015-03-02 Cytarabine+Methotrexate Intrathecal N N 220022881 METHOTREXATE + PEGASPARGASE
220020002 220009748 1.79 91.4 Disease modification (D) 2017-08-31 2017-10-23 CYTARABINE + MITOXANTRONE N N 220023457 MA
220020003 220018253 1.75 84.5 Palliative (P) 2017-08-16 2018-04-10 FIGARO TRIAL N N 220027021 ETOPOSIDE
220020004 220015142 null 67 Palliative (P) 2018-09-22 2018-09-25 Alemtuzumab + Cyclophos TBI Allo null N 220027990 CYTARABINE IT + METHOTREXATE
220020005 220020013 1.82 0 Palliative (P) 2017-04-06 2017-07-05 VINORELBINE 02 N 220028838 VINORELBINE
220020006 220009774 null 85.7 Curative (C) 2019-05-16 2019-05-24 PAC-E N N 220029686 ETOPOSIDE
220020007 220021037 1.77 86 Palliative (P) 2017-05-15 2017-11-01 MidAC N N 220031271 CYTARABINE + IDARUBICIN
220020008 220009783 null null null 2017-10-20 2017-10-24 CLADRIBINE + CYTARABINE + DAUNORUBICIN 99 null 220032124 ARSENIC TRIOXIDE
220020009 220009784 1.57 76.1 Not known (9) 2018-06-03 2018-08-24 Sorafenib 02 N 220032395 CAPECITABINE
220020010 220018262 null 16 Palliative (P) 2015-09-30 2015-10-28 Arsenic Triox + Tretinoin Ind W1-4 01 N 220033588 TRASTUZUMAB
220020011 220009790 1.65 86.9 Curative (C) 2017-04-21 2017-05-04 MACE N N 220033707 VINORELBINE
220020012 220009792 1.77 94.8 Palliative (P) 2018-08-26 2018-08-26 IPILIMUMAB + NIVOLUMAB 02 null 220034024 PEMETREXED
220020013 220009794 1.69 80 Curative (C) null 2014-01-16 FIGARO TRIAL N N 220034048 BUSULPHAN + CYCLO
220020014 220015162 1.7 101.699 null 2019-04-18 2019-07-03 FIGARO TRIAL N null 220034188 NHL 2003
220020015 220009801 1.61 null Curative (C) 2018-08-04 2018-08-18 CYTARABINE + Vosaroxin 01 N 220034318 TRASTUZUMAB
220020016 220009804 1.73 81.2 Disease modification (D) null 2014-11-25 AML LI-1 Trial 01 N 220034508 CISPLATIN + FLUOROURACIL
220020017 220009813 1.83 73.6 Curative (C) 2017-07-04 2017-07-11 INTERFERON N N 220035216 INTERFERON
220020018 220009820 null 77.1 null 2013-08-26 2013-09-27 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN null null 220035628 VINCRISTINE
220020019 220009822 1.65 58.8 Palliative (P) 2015-03-05 2015-03-05 GCLAC N N 220020987 FIGARO TRIAL
220020020 220009825 1.6 74.6 Curative (C) 2019-09-01 2019-09-05 LIPOSOMAL CYTARABINE N null 220024970 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220020021 220021040 1.8 64.7 Palliative (P) 2018-10-27 2019-03-02 Cisplatin 7 day N Y 220026545 VINORELBINE
220020022 220004055 1.69 0 Curative (C) 2015-04-04 2015-04-04 IMATINIB 02 N 220000145 IMATINIB
220020023 220004060 1.62 0 Disease modification (D) 2016-02-21 2016-10-12 Imatinib 400mg N N 220000223 IMATINIB
220020025 220004067 1.75 0 Curative (C) null 2018-04-21 Imatinib 400mg 2 N 220000374 IMATINIB
220020026 220004069 null null Disease modification (D) 2017-05-01 2017-05-01 IMATINIB N N 220000450 IMATINIB
220020027 220004077 0 100 Palliative (P) 2016-05-04 2016-05-05 Imatinib 400mg N N 220000633 IMATINIB
220020028 220012157 null null null 2018-03-14 2018-10-09 IMATINIB 2 N 220000723 IMATINIB
220020029 220004084 1.62 70 Curative (C) 2017-05-18 2017-06-18 IMATINIB N N 220000807 IMATINIB
220020030 220004087 null 83.5 Disease modification (D) 2017-08-12 2017-08-12 IMATINIB N N 220001016 IMATINIB